Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice

Neurodegenerative Diseases

Volumn 6, Issue 1-2, 2008, Pages 29-36

  Ozmen, Laurence ^a   Albientz, Anita ^a   Czech, Christian ^a   Jacobsen, Helmut ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Amyloid beta precursor protein; Beta amyloid; PS2APP transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; C57BL 6 MOUSE; CONTROLLED STUDY; DBA 2 MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TISSUE LEVEL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 21; COGNITION DISORDERS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; PRESENILIN-2; RNA, MESSENGER;

EID: 57449095649     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000170884     Document Type: Article

References (20)

1. Hardy J: Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154-159.
2. Glenner GG, Wong CW: Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984;122:1131-1135.
3. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D: APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006;38:24-26.
4. Carlsson GA, Borchelt DR, Dake A, Turner S, Danielson V, Coffin JD, Eckman C, Meiners J, Nilsen SP, Younkin SG, Hsiao KK: Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 1997;6:1951-1959.
5. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D: Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001;276:21562-21570.
6. Lehman EJ, Kulnane LS, Gao Y, Petriello MC, Pimpis KM, Younkin L, Dolios G, Wang R, Younkin SG, Lamb BT: Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Hum Mol Genet 2003;12:2949-2956.
7. Krezowski J, Knudson D, Ebeling C, Pitstick R, Giri RK, Schenk D, Westaway D, Younkin L, Younkin SG, Ashe KH, Carlson GA: Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression. Hum Mol Genet 2004;13:1989-1997.
8. Sebastiani G, Krzywkowski P, Dudal S, Yu M, Paquette J, Malo D, Gervais F, Tremblay P: Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice. Hum Mol Genet 2006;15:2313-2323.
9. Richards JG, Higgins GA, Ouagazzal AM, Ozmen L, Kew JN, Bohrmann B, Malherbe P, Brockhaus M, Loetscher H, Czech C, Huber G, Bluethmann H, Jacobsen H, Kemp JA: PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J Neurosci 2003;23:8989-9003.
10. Ida N, Masters CL, Beyreuther K: Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells. FEBS Lett 1996;394:174-178.
11. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC: Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 2001;158:1173-1177.
12. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T: Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice. Neurobiol Dis 2003;14:318-327.
13. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A; EURODEM Incidence Research Group: Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. Neurology 1999;53:1992-1997.
14. Ryman D, Gao Y, Lamb BT: Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease. Neurobiol Aging 2008;29:1190-1198.
15. Vidal M, Morris R, Grosveld F, Spanopoulo E: Tissue-specific control elements of the Thy-1 gene. EMBO J 1990;9:833-840.
16. Kelley KA, Friedrich VL Jr, Sonshine A, Hu Y, Lax J, Li J, Drinkwater D, Dressler H, Herrup K: Expression of Thy-1/lacZ fusion genes in the CNS of transgenic mice. Mol Brain Res 1994;24:261-274.
17. Overbeek PA, Aguilar-Cordova E, Hanten G, Schaffner DL, Patel P, Lebovitz RM, Lieberman MW: Coinjection strategy for visual identification of transgenic mice. Transgenic Res 1991;1:31-37.
18. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM: Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2001;98:8850-8855.
19. Gimelbrandt A, Hutchinson JN, Thompson BR, Chess A: Widespread monoallelic expression of human autosomes. Science 2007;318:1136-1140.
20. Hardy J: Amyloid double trouble. Nat Genet 2006;38:11-12.